- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03475654
A Prospective Trial of Virtual Home Rehabilitation After Burn Injury
December 5, 2024 updated by: Tam Pham, University of Washington
Virtual-Environment Home Rehabilitation: a Randomized Controlled Trial
The overarching goal for this prospective randomized controlled trial (PRCT) is to determine whether a virtual-environment, home-rehabilitation program improves functional outcomes for individuals after a burn injury.
Specifically, this study will test the efficacy of a technology-assisted rehabilitation program against current standard of home therapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a prospective, randomized controlled trial (PRCT) involving 50 adult burn survivors.
This study tests the efficacy of a technology-assisted rehabilitation program against current standard of home therapy.
There are two study groups for which subjects will be randomized: control and experimental.The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge.
The experimental group receives treatment as usual, in addition to training and use of the Jintronix platform for 3 months after hospital discharge.
Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98104
- Harborview Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age greater than or equal to 18 years old (no upper age limit)
- Ability to provide written, informed consent for study participation
- Ability to read and understand English
- Anticipated discharge to home environment
Home environment includes access to:
- television (larger than 20 inches in diameter with High Definition Multimedia Interface input (HDMI)
- internet and email address
- telephone (cell phone or landline)
Exclusion Criteria:
- Age less than 18 years
- Inability to provide written, informed consent for study participation
- Inability to read or understand English
- Delirium (as determined by the Delirium Observation Score test)
- Near-fall event at time of screening
- Pregnant women
- Discharge to non-home environment (e.g., shelter, street, skilled nursing facility)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: technology-assisted rehabilitation
The experimental group will receive treatment as usual, in addition to training with the Jintronix platform.
Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.
|
The Jintronix software platform, coupled with the Microsoft Kinect for movement capture, contains individualized exercise modules to increase ROM, endurance and strength.
Within this PRCT, online monitoring of activity and actigraphy measurements through a wearable device and completion of an online diary will provide enhanced monitoring of home activities.
|
|
Active Comparator: Usual care
The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge.
Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.
|
The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of physical activity
Time Frame: 3 months after study enrollment
|
level of activity among enrolled subjects by actigraphy
|
3 months after study enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of motion (ROM)
Time Frame: Study enrollment, 3, 6 and 12 months after enrollment
|
ROM by subjects in each group
|
Study enrollment, 3, 6 and 12 months after enrollment
|
|
Patient-reported outcome measures (PROMIS): sleep
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
|
Sleep and sleep disturbance Short Form (SF)8B PROMIS tool
|
Study enrollment, 3, 6, 12 months after enrollment
|
|
Patient-reported outcome measures (PROMIS): social participation
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
|
Participation in social roles and activities PROMIS tool SF6A
|
Study enrollment, 3, 6, 12 months after enrollment
|
|
Patient-reported outcome measures (PROMIS): pain interference
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
|
Pain interference PROMIS tool SF6A
|
Study enrollment, 3, 6, 12 months after enrollment
|
|
Patient-reported outcome measures (PROMIS): fatigue
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
|
Fatigue PROMIS tool SF6A
|
Study enrollment, 3, 6, 12 months after enrollment
|
|
Patient-reported outcome measures (PROMIS): stiffness
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
|
Stiffness impact Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-ME) V2.0
|
Study enrollment, 3, 6, 12 months after enrollment
|
|
Patient-reported outcome measures (PROMIS): mobility
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
|
Mobility PROMIS tool
|
Study enrollment, 3, 6, 12 months after enrollment
|
|
Patient-reported outcome measures (PROMIS): upper extremity
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
|
Upper extremity PROMIS SF7A
|
Study enrollment, 3, 6, 12 months after enrollment
|
|
Return to work/school
Time Frame: up to 1 year
|
Date when subject returns to work or school
|
up to 1 year
|
|
Patient reported level of activity difficulty
Time Frame: Weekly beginning 1 week after study enrollment and concluding 3 months after study enrollment
|
Using 1-5 difficulty scale (1=no difficulty and 5=very difficult), subject is asked how difficult his/her activity has been for the past 2 days
|
Weekly beginning 1 week after study enrollment and concluding 3 months after study enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tam Pham, MD, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 8, 2018
Primary Completion (Actual)
September 30, 2022
Study Completion (Actual)
September 30, 2022
Study Registration Dates
First Submitted
March 1, 2018
First Submitted That Met QC Criteria
March 22, 2018
First Posted (Actual)
March 23, 2018
Study Record Updates
Last Update Posted (Actual)
December 11, 2024
Last Update Submitted That Met QC Criteria
December 5, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003707
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn Scar
-
Riphah International UniversityRecruiting
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | ScarUnited States
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | Scar | Skin Graft ScarUnited States
-
Bispebjerg HospitalUnknownBurn Scar PatientsDenmark
-
University of PittsburghUnited States Department of DefenseTerminatedBurn Scar | Restrictive Scar Contracture | Restrictive Hypertrophic Scar | Burn Scar ContracturesUnited States
-
Centre hospitalier de l'Université de Montréal...Completed
-
Cairo UniversityCompletedBurns | Hypertrophic Scar | Burn Scar (Post-burn)Egypt
-
MTI UniversityCompleted
-
University Hospital, LinkoepingCompletedBurn Scar | Burns | Burn Second DegreeSweden
-
Kaiyang Lv, MD-PhDZimmer Medical Devices (Shanghai) Co., Ltd.RecruitingBurn Scar | Cryotherapy Effect | Scar; Previous Cesarean SectionChina
Clinical Trials on Technology-assisted rehabilitation
-
Vetrea Terveys OyKuopio University Hospital; City of KuopioRecruiting
-
University of HelsinkiHelsinki University Central Hospital; The Finnish Association of People with... and other collaboratorsCompletedSpinal Cord InjuriesFinland
-
The Fuzhou No 2 HospitalActive, not recruitingTibial FractureChina
-
University of British ColumbiaCompletedAssisted Reproductive Techniques
-
University of British ColumbiaCompleted
-
National Taiwan University HospitalUnknown
-
Escoles Universitaries GimbernatHospital Vall d'Hebron; Hospital Sant Joan de DeuActive, not recruitingCancer | Child Behavior | Child, Only | Neurologic Complication | Neurologic Gait DisorderSpain
-
State University of New York at BuffaloUnited States Department of DefenseCompleted
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Children's Hospital Medical Center, CincinnatiCompleted